A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Pacidamycin 5T | It is produced by the strain of Streptomyces coeruleorubidus NRRL 18370. Molecular formula: C36H44N8O12. Mole weight: 780.78. |  |
| Pacidamycin D | It is produced by the strain of Streptomyces coeruleorubidus NRRL 18370. It's a Pacidamycin antibiotic. It has the activity against pseudomonas aeruginosa with MIC of 4-16 μg/mL. it has no effect on other gram-negative bacteria and gram-positive bacteria, and no effect on drug-resistant pseudomonas aeruginosa. CAS No. 287107-95-3. Molecular formula: C32H41N9O10. Mole weight: 711.72. | |
| Packaging |  | |
| packaging bag | packaging bag. |  |
| Paclitaxel | Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 33069-62-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 500 mg; 1 g; 5 g. Product ID: HY-B0015. |  |
| Paclitaxel | Paclitaxel. Alternative Names: Paclitaxel 7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete benzenepropanoic acid deriv. CAS No. 33069-62-4. Purity: 95+%. Product ID: ACM33069624-2. Molecular formula: C47H51NO14. Mole weight: 853.91. IUPAC Name: [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate. Canonical SMILES: CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| Paclitaxel | Paclitaxel is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells.Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy. Group: Inhibitors. Alternative Names: NSC 125973, PTX. CAS No. 33069-62-4. Pack Sizes: 10mg. Product ID: S1150. Formula: C47H51NO14. Smiles: CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C. Storage Conditions: 2 years -80 in solvent. |  United States; Europe |
| Paclitaxel | Paclitaxel is a compound with anti-tumor activity extracted from the Pacific yew tree Taxus brevifolia. Paclitaxel is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells. Uses: Adcs cytotoxin. Alternative Names: Docetaxel EP Impurity F; BMS 181339-01; BMS181339-01; BMS-181339-01; Taxol A; Abraxane; Paxene; Taxol. Grades: >98%. CAS No. 33069-62-4. Molecular formula: C47H51NO14. Mole weight: 853.91. | |
| Paclitaxel | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C47H51NO14. CAS No. 33069-62-4. Prepack ID 51350888-1g. Molecular Weight 853.91. See USA prepack pricing. |  |
| Paclitaxel | 25mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C47H51NO14. CAS No. 33069-62-4. Prepack ID 51350888-25mg. Molecular Weight 853.91. See USA prepack pricing. | |
| Paclitaxel | 100mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C47H51NO14. CAS No. 33069-62-4. Prepack ID 51350888-100mg. Molecular Weight 853.91. See USA prepack pricing. | |
| Paclitaxel | Paclitaxel Inhibitor. Uses: Scientific use. Product Category: T0968. CAS No. 33069-62-4. |  |
| Paclitaxel-13C | Paclitaxel-13C. Group: Biochemicals. Alternative Names: Abraxane-13C. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. |  Worldwide |
| Paclitaxel C | Paclitaxel C. Group: Biochemicals. Alternative Names: N-Debenzoyl-N-hexanoylpaclitaxel; (-)-Taxuyunnanine; Taxol C. Grades: Highly Purified. CAS No. 153415-45-3. Pack Sizes: 1mg, 2mg, 5mg, 10mg. Molecular Formula: C46H57NO14. US Biological Life Sciences. | Worldwide |
| Paclitaxel-Curcumin Liposome (PEGylated) | Paclitaxel (PTX) is a taxane drug extracted from Taxus brevifolia, widely used in the treatment of breast cancer, ovarian cancer, non-small cell lung cancer, and other malignancies. Curcumin is a polyphenolic compound with various pharmacological effects such as tumor, anti-inflammatory and antioxidant. This product is a pre-formulated liposome encapsulating Paclitaxel and Curcumin. It is only for research purposes. Group: Drug-loaded liposome. |  |
| Paclitaxel-d5 | Paclitaxel-d5 is a deuterium-labeled Paclitaxel. Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1129540-33-5. Pack Sizes: 500 μg; 1 mg; 5 mg; 10 mg. Product ID: HY-B0015S. | |
| Paclitaxel-d5 (Taxol-d5) | An antineoplastic. Used in the study of structure and function of microtubles into tubulin. Group: Biochemicals. Alternative Names: Taxol-d5. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Paclitaxel-DBCO | Paclitaxel-DBCO is Paclitaxel (HY-B0015) modified with a DBCO linker. Uses: Scientific research. Category: Signaling pathways. CAS No. 2414212-43-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-177999. | |
| Paclitaxel EP Impurity A | Paclitaxel EP Impurity A. Uses: For analytical and research use. Alternative Names: Iso Cephalomannine; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-12-(((E)-2-methylbut-2-enoyl)oxy)-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocycl. CAS No. 173101-54-7. Molecular formula: C45H53NO14. Mole weight: 831.90. Catalog: APB173101547. |  |
| Paclitaxel EP Impurity A | Paclitaxel EP Impurity A is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4,10β-Bis(acetyloxy)-13α-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1,7β-dihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-yl (2E)-2-methylbut-2-enoate; 2-O-Debenzoyl-2-O-tigloylpaclitaxel; Iso Cephalomannine; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-12-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; Isocephalomannine; Paclitaxel impurity A; 2-Debenzoyl-2-tigloylpaclitaxel; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-12-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-β-(benzoylamino)-α-hydroxybenzenepropanoate; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, 6,12b-bis(acetyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-12-[(2-methyl-1-oxo-2-butenyl)oxy]-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11&alp | |
| Paclitaxel EP Impurity B | Paclitaxel EP Impurity B. Uses: For analytical and research use. CAS No. 71610-00-9. Molecular formula: C45H53NO14. Mole weight: 831.91. Catalog: APB71610009. | |
| Paclitaxel EP Impurity B (Cephalomannine) | Cephalomannine is an active anti-cancer agent obtained from Taxus yunnanensis and has an antineoplastic effect on tumors found in mice. Uses: Antitumor. Alternative Names: 4,10β-Bis(acetyloxy)-1,7β-dihydroxy-13α-[[(2R,3S)-2-hydroxy-3-[[(2E)-2-methylbut-2-enoyl]amino]-3-phenylpropanoyl]oxy]-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; N-Debenzoyl-N-tigloylpaclitaxel; Benzenepropanoic acid, α-hydroxy-β-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; NSC 318735; Taxol B; USP Paclitaxel Related Compound A; Paclitaxel impurity B; Benzenepropanoic acid, α-hydroxy-β-[(2-methyl-1-oxo-2-butenyl)amino]-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α[αR*,βS*(E)],11α,12α,12aα,12bα]]-; Paclitaxel Related Compound A; Paclitaxel USP Related Compound A. Grades: 96%. CAS No. 71610-00-9. Molecular formula: C45H53NO14. Mole weight: 831.90. | |
| Paclitaxel EP Impurity C | Paclitaxel EP Impurity C is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4,10β-Bis(acetyloxy)-13α-[[(2R,3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy]-1,7β-dihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; N-Debenzoyl-N-hexanoylpaclitaxel; Paclitaxel C; (-)-Taxuyunnanine; Taxol C; Taxuyunnanine; Taxuyunnanine A; Benzenepropanoic acid, α-hydroxy-β-[(1-oxohexyl)amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; Benzenepropanoic acid, α-hydroxy-β-[(1-oxohexyl)amino]-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-; Paclitaxel pentyl analog; Baccatin III 13-ester with (2R,3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoic acid. Grades: ≥95%. CAS No. 153415-45-3. Molecular formula: C46H57NO14. Mole weight: 847.97. | |
| Paclitaxel EP Impurity C | Paclitaxel EP Impurity C. Uses: For analytical and research use. Alternative Names: (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-hexanamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate. CAS No. 153415-45-3. Molecular formula: C46H57NO14. Mole weight: 847.94. Catalog: APB153415453. | |
| Paclitaxel EP Impurity D | Paclitaxel EP Impurity D. Uses: For analytical and research use. Alternative Names: 7-epi-Cephalomannine; (2aR,4R,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-4,11-dihydroxy-9-(((2R,3S)-2-hydroxy-3-((E)-2-methylbut-2-enamido)-3-phenylpropanoyl)oxy)-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate. CAS No. 150547-36-7. Molecular formula: C45H53NO14. Mole weight: 831.9. Catalog: APB150547367. | |
| Paclitaxel EP Impurity D | Paclitaxel EP Impurity D is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4,10β-Bis(acetyloxy)-1,7α-dihydroxy-13α-[[(2R,3S)-2-hydroxy-3-[[(2E)-2-methylbut-2-enoyl]amino]-3-phenylpropanoyl]oxy]-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; N-Debenzoyl-N-tigloyl-7-epi-paclitaxel; 7-epi-Cephalomannine; Benzenepropanoic acid, α-hydroxy-β-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]amino]-, (2aR,4R,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; Benzenepropanoic acid, α-hydroxy-β-[(2-methyl-1-oxo-2-butenyl)amino]-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4α,4aβ,6β,9α[αR*,βS*(E)],11α,12α,12aα,12bα]]-; 7-Epicephalomannine; Paclitaxel Impurity D. Grades: ≥95%. CAS No. 150547-36-7. Molecular formula: C45H53NO14. Mole weight: 831.90. | |
| Paclitaxel EP Impurity E | Paclitaxel EP Impurity E is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4,10β-Bis(acetyloxy)-13α-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1,7α-dihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; 7-epi-Paclitaxel; 7-Epipaclitaxel; 7-Epitaxol; 7-epi-Taxol; Epitaxol; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4R,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4α,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-; (2aR,4R,4aS,6R,9S,11S,12S,12bS)-9-(((2R,3S)-3-Benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-3,4,4a,5,6,9,10,11,12,12a-decahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b(2aH)-diyl diacetate. Grades: >98%. CAS No. 105454-04-4. Molecular formula: C47H51NO14. Mole weight: 853.91. | |
| Paclitaxel EP Impurity E | Paclitaxel EP Impurity E. Uses: For analytical and research use. Alternative Names: 7-epi Paclitaxel; (2aR,4R,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate. CAS No. 105454-04-4. Molecular formula: C47H51NO14. Mole weight: 853.91. Catalog: APB105454044. | |
| Paclitaxel EP Impurity F | Paclitaxel EP Impurity F is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4,10β-Bis(acetyloxy)-13α-[[(2R,3S)-3-[hexanoyl(methyl)-amino]-2-hydroxy-3-phenylpropanoyl]oxy]-1,7β-dihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; N-Debenzoyl-N-hexanoyl-N-methylpaclitaxel; N-Methylpaclitaxel C; N-Methyltaxol C; Benzenepropanoic acid, α-hydroxy-β-[methyl(1-oxohexyl)amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; Benzenepropanoic acid, α-hydroxy-β-[methyl(1-oxohexyl)amino]-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-; N-Methyl taxol C; Paclitaxel Impurity F. Grades: ≥95%. CAS No. 153083-53-5. Molecular formula: C47H59NO14. Mole weight: 861.99. | |
| Paclitaxel EP Impurity F | Paclitaxel EP Impurity F. Uses: For analytical and research use. Alternative Names: N-methylpaclitaxel C; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-4,11-dihydroxy-9-(((2R,3S)-2-hydroxy-3-(N-methylhexanamido)-3-phenylpropanoyl)oxy)-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate. CAS No. 153083-53-5. Molecular formula: C47H59NO14. Mole weight: 861.97. Catalog: APB153083535. | |
| Paclitaxel EP Impurity G | Paclitaxel EP Impurity G. Uses: For analytical and research use. Alternative Names: Paclitaxel Impurity 22; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. CAS No. 78432-77-6. Molecular formula: C45H49NO13. Mole weight: 811.87. Catalog: APB78432776. | |
| Paclitaxel EP Impurity G | Paclitaxel EP Impurity G is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4-(Acetyloxy)-13α-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; 10-O-Deacetylpaclitaxel; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, 12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-; 10-Deacetylpaclitaxel; 10-Deacetyltaxol; 10-Deacetyltaxol A; 10-Desacetylpaclitaxel; 10-Desacetyltaxol; 10-O-Deacetyltaxol; Paclitaxel impurity G; (2aR,4S,4aS,6R,9S,11S,12S,12bS)-12b-Acetoxy-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. Grades: >98%. CAS No. 78432-77-6. Molecular formul | |
| Paclitaxel EP Impurity H | Paclitaxel EP Impurity H is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4-(Acetyloxy)-13α-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1,7α,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; 10-O-Deacetyl-7-epi-paclitaxel; 7-Epi-10-deacetyltaxol; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4R,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; 10-Deacetyl-7-epi-paclitaxel; 10-Deacetyl-7-epi-taxol; 10-Deacetyl-7-epipaclitaxel; 10-Deacetyl-7-epitaxol; 10-Desacetyl-7-epipaclitaxel; 7-epi-10-Deacetylpaclitaxel; Ormosin VI; USP Paclitaxel Related Compound B; Paclitaxel USP Related Compound B; Paclitaxel Related Compound B. Grades: ≥95%. CAS No. 78454-17-8. Molecular formula: C45H49NO13. Mole weight: 811.88. | |
| Paclitaxel EP Impurity H | Paclitaxel EP Impurity H. Uses: For analytical and research use. Alternative Names: Paclitaxel USP Related Compound B; 7-epi-10-Desacetyl-Paclitaxel; (2aR,4R,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. CAS No. 78454-17-8. Molecular formula: C45H49NO13. Mole weight: 811.87. Catalog: APB78454178. | |
| Paclitaxel EP Impurity I | Paclitaxel EP Impurity I is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4-(Acetyloxy)-10β,13α-bis[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1,7β-dihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; 10-O-[(2R,3S)-3-Benzamido-2-hydroxy-3-phenylpropanoyl]-10-O-deacetylpaclitaxel; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, 1,1'-[(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxete-6,9-diyl] ester, (αR,α'R,βS,β'S)-; 1,1'-[(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxete-6,9-diyl] bis[(αR,βS)-β-(benzoylamino)-α-hydroxybenzenepropanoate]; 10,13-Bissidechainpaclitaxe; Baccatin III 13-ester with (2R,3S)-2-hydroxy-3-phenyl-3-(phenylcarbonylamino)propanoic acid, 10-ester with (2S,3S)-2-hydroxy-3-phenyl-3-(phenylcarbonylamino)propanoic acid; Paclitaxel 10,13-Bis Side Chain. Grades: ≥95%. CAS No. 2157462-42-3. Molecular formula: C61H62N2O16. Mole weight: 1079.15. | |
| Paclitaxel EP Impurity I | Paclitaxel EP Impurity I. Uses: For analytical and research use. Alternative Names: Paclitaxel 10,13-Bis Side Chain; (2R,2'R,3S,3'S)-(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,9-diyl bis(3-benzamido-2-hydroxy-3-phenylpropanoate). CAS No. 2157462-42-3. Molecular formula: C61H62N2O16. Mole weight: 1079.15. Catalog: APB2157462423. | |
| Paclitaxel EP Impurity J | Paclitaxel EP Impurity J is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4-(Acetyloxy)-13α-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1,7β-dihydroxy-9-oxo-10β-[(3-oxobutanoyl)oxy]-5β,20-epoxytax-11-en-2α-yl benzoate; 10-O-Deacetyl-10-O-(3-oxobutanoyl)paclitaxel; 10-Acetoacetyl Paclitaxel; 10-Acetoacetyl Abraxane; 10-Acetoacetyl Genaxol; 10-Acetoacetyl Genetaxyl; 10-Acetoacetyl Onxal; 10-Acetoacetyl Pacliex; 10-Acetoacetyl (-)-Paclitaxel; 10-Acetoacetyl Taxol; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-6-(1,3-dioxobutoxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-β-(benzoylamino)-α-hydroxybenzenepropanoate; (2α,5β,7β,10β,13α)-10-(Acetoacetyloxy)-4-acetoxy-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-6-(1,3-dioxobutoxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; 10-Acetoacetylpaclitaxel. Grades: 90%. CAS No. 2757197-2 | |
| Paclitaxel EP Impurity J | Paclitaxel EP Impurity J. Uses: For analytical and research use. CAS No. 2757197-26-3. Molecular formula: C49H53NO15. Mole weight: 895.96. Catalog: APB2757197263. | |
| Paclitaxel EP Impurity J | Paclitaxel EP Impurity J. Uses: For analytical and research use. Alternative Names: 10-Acetoacetyl Paclitaxel; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-6-((3-oxobutanoyl)oxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. Molecular formula: C49H53NO15. Mole weight: 895.94. Catalog: APB01943. | |
| Paclitaxel EP Impurity K | Paclitaxel EP Impurity K. Uses: For analytical and research use. Alternative Names: (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4-((triethylsilyl)oxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1. CAS No. 148930-55-6. Molecular formula: C53H65NO14Si. Mole weight: 968.17. Catalog: APB148930556. | |
| Paclitaxel EP Impurity K | Paclitaxel EP Impurity K is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4,10β-bis(acetyloxy)-13α-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1-hydroxy-9-oxo-7β-[(triethylsilyl)oxy]-5β,20-epoxytax-11-en-2α-yl benzoate; 7-O-(Triethylsilanyl)paclitaxel; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4-[(triethylsilyl)oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4-[(triethylsilyl)oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-; 7-(Triethylsilyl)taxol; 7-O-(Triethylsilyl)paclitaxel; 7-O-(Triethylsilyl)taxol; 7-Tes-paclitaxel. Grades: ≥95%. CAS No. 148930-55-6. Molecular formula: C53H65NO14Si. Mole weight: 968.19. | |
| Paclitaxel EP Impurity L | Paclitaxel EP Impurity L is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4,7β,10β-tris(acetyloxy)-13α-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1-hydroxy-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; 7-O-Acetylpaclitaxel; 7-Acetyl Paclitaxel; 7-Acetyltaxol; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-4,6,12b-Tris(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-β-(benzoylamino)-α-hydroxybenzenepropanoate; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, 4,6,12b-tris(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-; 7-Acetylpaclitaxel. Grades: ≥95%. CAS No. 92950-39-5. Molecular formula: C49H53NO15. Mole weight: 895.94. | |
| Paclitaxel EP Impurity L | Paclitaxel EP Impurity L. Uses: For analytical and research use. Alternative Names: 7-Acetyl Paclitaxel; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-4,6,12b-triyl triacetate. CAS No. 92950-39-5. Molecular formula: C49H53NO15. Mole weight: 895.94. Catalog: APB92950395. | |
| Paclitaxel EP Impurity M | Paclitaxel EP Impurity M. Uses: For analytical and research use. Alternative Names: Paclitaxel Oxetane Ring-Opened 3-Acetyl 4-Benzoyl Impurity; (1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-8-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-4-((benzoyloxy)methyl)-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-1,2,3,4,4a,5,6,7,8,11,12,12a-d. CAS No. 932042-85-8. Molecular formula: C47H53NO15. Mole weight: 871.92. Catalog: APB932042858. | |
| Paclitaxel EP Impurity M | Paclitaxel EP Impurity M is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 5β,10β-bis(acetyloxy)-13α-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1,2α,4,7β-tetrahydroxy-9-oxotax-11-en-20-yl benzoate; Paclitaxel Oxetane Ring-Opened 3-Acetyl 4-Benzoyl Impurity; (1S,3R,4S,4aR,5S,6S,8S,11R,12aS)-8-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-4-((benzoyloxy)methyl)-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-6,10-methanobenzo[10]annulene-3,11-diyl diacetate; Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (1S,3R,4S,4aR,5S,6S,8S,11R,12aS)-3,11-bis(acetyloxy)-4-[(benzoyloxy)methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-methanobenzocyclodecen-8-yl ester, (αR,βS)-; (1S,3R,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-methanobenzocyclodecen-8-yl (αR,βS)-β-(benzoylamino)-α-hydroxybenzenepropanoate. Grades: ≥95%. CAS No. 2850227-40-4. Molecular formula: C47H53NO15. Mole weight: 871.92. | |
| Paclitaxel EP Impurity N | Baccatin III is a tetracyclic diterpenoid isolated from the barks of Taxus yunnanensis. It can be used as an intermediate in the synthesis of paclitaxel. Alternative Names: 4,10β-Bis(acetyloxy)-1,7β,13α-trihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; 13-O-de[(2R,3S)-3-Benzamido-2-hydroxy-3-phenylpropanoyl]paclitaxel; Baccatin III; 7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-4,9,11-trihydroxy-4a,8,13,13-tetramethyl-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-4,9,11-trihydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one; 7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-4,9,11-trihydroxy-4a,8,13,13-tetramethyl-, [2aR-(2aα,4β,4aβ,6β,9α,11α,12α,12aα,12bα)]-; NSC 330753; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(Benzoyloxy)-4,9,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-3,4,4a,5,6,9,10,11,12,12a-decahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b(2aH)-diyl diacetate. Grades: ≥95%. CAS No. 27548-93-2. Molecular formula: C31H38O11. Mole weight: 586.63. | |
| Paclitaxel EP Impurity N | Paclitaxel EP Impurity N. Uses: For analytical and research use. Alternative Names: Baccatin III; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-4,9,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate. CAS No. 27548-93-2. Molecular formula: C31H38O11. Mole weight: 586.63. Catalog: APB27548932. | |
| Paclitaxel EP Impurity O | Paclitaxel EP Impurity O. Uses: For analytical and research use. Alternative Names: N-cinnamoyl-N-debenzoylpaclitaxel; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-cinnamamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate. CAS No. 219783-77-4. Molecular formula: C49H53NO14. Mole weight: 879.94. Catalog: APB219783774. | |
| Paclitaxel EP Impurity O | Paclitaxel EP Impurity O is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4,10β-bis(acetyloxy)-1,7β-dihydroxy-13α-[[(2R,3S)-2-hydroxy-3-phenyl-3-[[(2E)-3-phenylprop-2-enoyl]amino]propanoyl]oxy]-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; N-Cinnamoyl-N-debenzoylpaclitaxel; Paclitaxel Impurity O; Benzenepropanoic acid, α-hydroxy-β-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]amino]benzenepropanoate; Benzenepropanoic acid, α-hydroxy-β-[[(2E)-1-oxo-3-phenyl-2-propenyl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-. Grades: ≥95%. CAS No. 219783-77-4. Molecular formula: C49H53NO14. Mole we | |
| Paclitaxel EP Impurity P | Paclitaxel EP Impurity P is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4,10β-Bis(acetyloxy)-1,7β-dihydroxy-13α-[[(2R,3S)-2-hydroxy-3-phenyl-3-(2-phenylacetamido)propanoyl]oxy]-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; N-Debenzoyl-N-(phenylacetyl)paclitaxel; Benzenepropanoic acid, α-hydroxy-β-[(phenylacetyl)amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[(phenylacetyl)amino]benzenepropanoate; Benzenepropanoic acid, α-hydroxy-β-[(phenylacetyl)amino]-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-; Taxol F; N-Debenzoyl-N-phenylacetyl taxol; Paclitaxel Benzyl analog; Baccatin III 13-ester with (2R,3S)-2-hydro | |
| Paclitaxel EP Impurity P | Paclitaxel EP Impurity P. Uses: For analytical and research use. Alternative Names: (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-4,11-dihydroxy-9-(((2R,3S)-2-hydroxy-3-phenyl-3-(2-phenylacetamido)propanoyl)oxy)-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate. CAS No. 173101-56-9. Molecular formula: C48H53NO14. Mole weight: 867.93. Catalog: APB173101569. | |
| Paclitaxel EP Impurity Q | Paclitaxel EP Impurity Q. Uses: For analytical and research use. Alternative Names: (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-((E)-hex-2-enamido)-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate. CAS No. 502626-06-4. Molecular formula: C46H55NO14. Mole weight: 845.93. Catalog: APB502626064. | |
| Paclitaxel EP Impurity Q | Paclitaxel EP Impurity Q is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4,10β-Bis(acetyloxy)-13α-[[(2R,3S)-3-[[(3E)-hex-3-enoyl]amino]-2-hydroxy-3-phenylpropanoyl]oxy]-1,7β-dihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel; Paclitaxel Impurity Q; Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]benzenepropanoate; 3'',4''-Dehydropaclitaxel C. Grades: ≥95%. CAS No. 2243233-98-7. Molecular formula: C46H55NO14. Mole weight: 845.95. | |
| Paclitaxel EP Impurity R | Paclitaxel EP Impurity R. Uses: For analytical and research use. CAS No. 159001-25-9. Molecular formula: C45H55NO14. Mole weight: 833.93. Catalog: APB159001259. | |
| Paclitaxel EP Impurity R | Paclitaxel EP Impurity R is an impurity of Paclitaxel, which is a mitotic inhibitor used in cancer chemotherapy. Alternative Names: 4,10β-Bis(acetyloxy)-1,7β-dihydroxy-13α-[[(2R,3S)-2-hydroxy-3-[[(2S)-2-methylbutanoyl]amino]-3-phenylpropanoyl]oxy]-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate; N-Debenzoyl-N-[(2S)-2-methylbutanoyl]paclitaxel; Taxol E; Paclitaxel Impurity R; Benzenepropanoic acid, α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate; Benzenepropanoic acid, α-hydroxy-β-[(2-methyl-1-oxobutyl)amino]-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α[αR*,βS*(S*)],11α,12α,12aα,12bα]]-. Grades: ≥95%. CAS No. | |
| Paclitaxel EP Impurity R | Paclitaxel EP Impurity R. Uses: For analytical and research use. Alternative Names: (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-4,11-dihydroxy-9-(((2R,3S)-2-hydroxy-3-((S)-2-methylbutanamido)-3-phenylpropanoyl)oxy)-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]. Molecular formula: C45H55NO14. Mole weight: 833.92. Catalog: APB01944. | |
| Paclitaxel Half Synthetic | Paclitaxel Half Synthetic. CAS No. 33069-62-4. Molecular formula: C47H51NO14. Mole weight: 853.906g/mol. Purity: 99.99%. | |
| Paclitaxel Impurity 20 | Paclitaxel Impurity 20. Uses: For analytical and research use. CAS No. 2097541-16-5. Molecular formula: C28H29NO5. Mole weight: 459.54. Catalog: APB2097541165. | |
| Paclitaxel Impurity 21 | Paclitaxel Impurity 21. Uses: For analytical and research use. Alternative Names: (1S,2S,4S,6R,7aS,8S,9aR,11aS)-4-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-1-(benzoyloxy)-2,8-dihydroxy-5,7a,12,12-tetramethyl-7-oxododecahydro-1H-2,5a-methanocyclohepta[3,3a]indeno[5,4-b]oxete-6,11a-diyl diacetate. CAS No. 146139-03-9. Molecular formula: C47H51NO14. Mole weight: 853.91. Catalog: APB146139039. | |
| Paclitaxel Impurity 22 (Docetaxel Impurity 12) | Paclitaxel Impurity 22 (Docetaxel Impurity 12). Uses: For analytical and research use. CAS No. 165173-47-7. Molecular formula: C29H36O10. Mole weight: 544.6. Catalog: APB165173477. | |
| Paclitaxel Impurity 23 | Paclitaxel Impurity 23. Uses: For analytical and research use. Alternative Names: (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-9-((triethylsilyl)oxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate. CAS No. 208406-86-4. Molecular formula: C37H52O11Si. Mole weight: 700.89. Catalog: APB208406864. | |
| Paclitaxel Impurity 35 | Paclitaxel Impurity 35. Uses: For analytical and research use. CAS No. 153212-75-0. Molecular formula: C47H51NO15. Mole weight: 869.92. Catalog: APB153212750. | |
| Paclitaxel Impurity 36 (Larotaxel) | Paclitaxel Impurity 36 (Larotaxel). Uses: For analytical and research use. CAS No. 156294-36-9. Molecular formula: C47H51NO15. Mole weight: 869.92. Catalog: APB156294369. | |
| Paclitaxel Impurity 37 | Paclitaxel Impurity 37. Uses: For analytical and research use. CAS No. 1262147-55-6. Molecular formula: C24H21NO5. Mole weight: 403.43. Catalog: APB1262147556. | |
| Paclitaxel Impurity 45 | Paclitaxel Impurity 45. Uses: For analytical and research use. CAS No. 32981-90-1. Molecular formula: C33H40O12. Mole weight: 628.66. Catalog: APB32981901. | |
| Paclitaxel Impurity 46 | Paclitaxel Impurity 46. Uses: For analytical and research use. CAS No. 173101-59-2. Molecular formula: C41H49NO13. Mole weight: 763.84. Catalog: APB173101592. | |
| Paclitaxel Impurity 47 | Paclitaxel Impurity 47. Uses: For analytical and research use. CAS No. 173101-47-8. Molecular formula: C42H51NO13. Mole weight: 777.86. Catalog: APB173101478. | |
| Paclitaxel Impurity 4 (Docetaxel Impurity 33) | Paclitaxel Impurity 4 (Docetaxel Impurity 33). Uses: For analytical and research use. CAS No. 154083-99-5. Molecular formula: C29H36O11. Mole weight: 560.6. Catalog: APB154083995. | |
| Paclitaxel Impurity 5 | Paclitaxel Impurity 5. Uses: For analytical and research use. CAS No. 172018-16-5. Molecular formula: C29H36O10. Mole weight: 544.6. Catalog: APB172018165. | |
| Paclitaxel Impurity 5 | Paclitaxel Impurity 5. Uses: For analytical and research use. Alternative Names: (2aR,4S,4aS,6R,11S,12S,12aR,12bS)-12b-acetoxy-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5,9-dioxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. CAS No. 92950-42-0. Molecular formula: C29H34O10. Mole weight: 542.57. Catalog: APB92950420. | |
Our database is helping our users find suppliers everyday.
